64. Provost, P.R. and Y. Tremblay, Mouse 3alpha-hydroxysteroid <strong>de</strong>hydrogenase mRNA: a marker of lungmaturity. J Steroid Biochem Mol Biol, 2007. 103(1): p. 61-4.65. Floros, J., H.C. Nielsen, and J.S. Torday, Dihydrotestosterone blocks fetal lung fibroblast-pneumonocytefactor at a pretranslational <strong>le</strong>vel. J Biol Chem, 1987. 262(28): p. 13592-8.66. Torday, J.S., Dihydrotestosterone inhibits fibroblast-pneumonocyte factor-mediated synthesis of saturatedphosphatidylcholine by fetal rat lung cells. Biochim Biophys Acta, 1985. 835(1): p. 23-8.67. K<strong>le</strong>in, J.M. and H.C. Nielsen, Androgen regulation of epi<strong>de</strong>rmal growth factor receptor binding activityduring fetal rabbit lung <strong>de</strong>velopment. J Clin Invest, 1993. 91(2): p. 425-31.68. Pereira, S., et al., Transforming growth factor beta 1 binding and receptor kinetics in fetal mouse lungfibroblasts. Proc Soc Exp Biol Med, 1998. 218(1): p. 51-61.69. McMillan, E.M., G.M. King, and I.Y. Adamson, Sex hormones influence growth and surfactant production infetal lung explants. Exp Lung Res, 1989. 15(2): p. 167-79.70. Nielsen, H.C., et al., Coordination of growth and differentiation in the fetal lung. Exp Cell Res, 1990. 188(1):p. 89-96.71. Sweezey, N.B., F. Ghibu, and S. Gagnon, Sex hormones regulate CFTR in <strong>de</strong>veloping fetal rat lung epithelialcells. Am J Physiol, 1997. 272(5 Pt 1): p. L844-51.72. O'Brodovich, H., et al., Amilori<strong>de</strong>-insensitive Na+ and fluid absorption in the mammalian distal lung. Am JPhysiol Lung Cell Mol Physiol, 2008. 294(3): p. L401-8.73. Wilson, S.M., R.E. Olver, and D.V. Walters, Developmental regulation of lumenal lung fluid and e<strong>le</strong>ctrolytetransport. Respir Physiol Neurobiol, 2007. 159(3): p. 247-55.74. Nielsen, H.C., Androgen receptors influence the production of pulmonary surfactant in the testicularfeminization mouse fetus. J Clin Invest, 1985. 76(1): p. 177-81.75. Kimura, Y., et al., Expression of androgen receptor and 5alpha-reductase types 1 and 2 in early gestationfetal lung: a possib<strong>le</strong> correlation with branching morphogenesis. Clin Sci (Lond), 2003. 105(6): p. 709-13.76. Dammann, C.E., et al., Androgen regulation of signaling pathways in late fetal mouse lung <strong>de</strong>velopment.Endocrinology, 2000. 141(8): p. 2923-9.77. Boonyaratanakornkit, V. and D.P. Edwards, Receptor mechanisms mediating non-genomic actions of sexsteroids. Semin Reprod Med, 2007. 25(3): p. 139-53.78. Simard, M., P.R. Provost, and Y. Tremblay, Sexually dimorphic gene expression that overlaps maturation oftype II pneumonocytes in fetal mouse lungs. Reprod Biol Endocrinol, 2006. 4: p. 25.79. Karcher, R., et al., Gestational age-specific predicted risk of neonatal respiratory distress syndrome usinglamellar body count and surfactant-to-albumin ratio in amniotic fluid. Am J Obstet Gynecol, 2005. 193(5): p.1680-4.53
80. Bahasadri, S. and N. Changizi, Association between lamellar body count and respiratory distress inneonates. Saudi Med J, 2005. 26(9): p. 1414-6.81. Hunter, L.A., D.S. McKenna, and M.A. Baptista, Comparison of lamellar body counts using light microscopywith standard coulter counter techniques to assess fetal lung maturity. Gynecol Obstet Invest, 2006. 61(1): p.29-33.82. Bazowska, G., A. Jendryczko, and J. Dudkiewicz, Evaluation of amniotic fluid elastolytic activity: can it be amethod of fetal lung maturity assessment? A comparison with Gluck's L/S test. Acta Genet Med Gemellol(Roma), 1994. 43(3-4): p. 185-92.83. Gluck, L., et al., The biochemical <strong>de</strong>velopment of surface activity in mammalian lung. I. The surface-activephospholipids; the separation and distribution of surface-active <strong>le</strong>cithin in the lung of the <strong>de</strong>veloping rabbitfetus. Pediatr Res, 1967. 1(4): p. 237-46.84. Gluck, L., M. Sribney, and M.V. Kulovich, The biochemical <strong>de</strong>velopment of surface activity in mammalianlung. II. The biosynthesis of phospholipids in the lung of the <strong>de</strong>veloping rabbit fetus and newborn. Pediatr Res,1967. 1(4): p. 247-65.85. Liu, K.Z., T.C. Dembinski, and H.H. Mantsch, Prediction of RDS from amniotic fluid analysis: a comparison ofthe prognostic value of TLC and infra-red spectroscopy. Prenat Diagn, 1998. 18(12): p. 1267-75.86. Hagen, E., J.C. Link, and F. Arias, A comparison of the accuracy of the TDx-FLM assay, <strong>le</strong>cithinsphingomyelinratio, and phosphatidylglycerol in the prediction of neonatal respiratory distress syndrome.Obstet Gynecol, 1993. 82(6): p. 1004-8.87. Herbert, W.N., J.F. Chapman, and M.M. Schnoor, Ro<strong>le</strong> of the TDx FLM assay in fetal lung maturity. Am JObstet Gynecol, 1993. 168(3 Pt 1): p. 808-12.88. Haymond, S., et al., A direct comparison between lamellar body counts and fluorescent polarizationmethods for predicting respiratory distress syndrome. Am J Clin Pathol, 2006. 126(6): p. 894-9.89. Gomella, T.e.a., Neonatalogy. 5th ed. 2003, New York: McGraw-Hill Medical publishers. 710.90. Parmigiani, S., E. Solari, and G. Bevilacqua, Current concepts on the pulmonary surfactant in infants. JMatern Fetal Neonatal Med, 2005. 18(6): p. 369-80.91. Korfhagen, T.R., et al., Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl AcadSci U S A, 1996. 93(18): p. 9594-9.92. K<strong>le</strong>in, J.M., et al., Transient surfactant protein B <strong>de</strong>ficiency in a term infant with severe respiratory failure. JPediatr, 1998. 132(2): p. 244-8.93. Mazela, J., et al., Evolution of pulmonary surfactants for the treatment of neonatal respiratory distresssyndrome and paediatric lung diseases. Acta Paediatr, 2006. 95(9): p. 1036-48.94. Zemke, A.C., et al., Mo<strong>le</strong>cular Staging of Epithlieial Maturation Using Secretory Cell-Specific Genes asMarkers. Am J Respir Cell Mol Biol, 2008.54
- Page 7 and 8: REMERCIEMENTSBien que leurs noms ne
- Page 9 and 10: INTRODUCTIONAu cours des dernières
- Page 11 and 12: L’influence de la prématurité e
- Page 13 and 14: INTRODUCTIONL’accouchement préma
- Page 15 and 16: Tableau 2Statistiques de survie des
- Page 17 and 18: indiquent que l’obésité réduir
- Page 19 and 20: Tableau 5Percentiles des poids (g)
- Page 21 and 22: détresse respiratoire que les peti
- Page 23 and 24: confirmée par plusieurs autres ess
- Page 25 and 26: Références1. Reed DM, Stanley FJ:
- Page 27 and 28: 32. Honest H, Bachmann LM, Ngai C,
- Page 29 and 30: L’influence de la prématurité e
- Page 31 and 32: laboratoire du Dr Yves Tremblay. El
- Page 33 and 34: Introductionlusieurs paramètres pe
- Page 35 and 36: Le canal artériel crée une joncti
- Page 37 and 38: Figure 1. Histologie du poumon de s
- Page 39 and 40: cette variation allélique. D’aut
- Page 41 and 42: Chez le rat, la DHT réduit, dans d
- Page 43 and 44: les mécanismes subtils de la matur
- Page 45 and 46: Signaux de communication entre le m
- Page 47 and 48: FONDEMENTS BIOMÉDICAUX DES THÉRAP
- Page 49 and 50: L’OCCLUSION TRACHÉALECette techn
- Page 51 and 52: 16. Derin, B.G., et al., Immunohist
- Page 53: 49. Nielsen, H.C., H.M. Zinman, and
- Page 57 and 58: 111. Tremblay, L.O., et al., Respir
- Page 59 and 60: L’influence de la prématurité e
- Page 61 and 62: INTRODUCTIONAlors que les médias n
- Page 63 and 64: scolaire professionnelle et ils ont
- Page 65 and 66: l’âge de 6 ans présenteraient a
- Page 67 and 68: S’il s’agit en plus d'un enfant
- Page 69 and 70: RÉFÉRENCES1. O'Shea TM, Kuban KC,
- Page 71 and 72: 31. Garel M, Bahuaud M, Blondel B:
- Page 73 and 74: PRÉSENTATION DE L'AUTEUREMireille
- Page 75 and 76: non) et selon les décisions prises
- Page 77 and 78: L’ÊTRE HUMAIN ET LA SÉLECTION N
- Page 79 and 80: pratiques aient évolué depuis ce
- Page 81 and 82: survivants soient disponibles, des
- Page 83 and 84: de certitude scientifique sur les r
- Page 85 and 86: LA PLACE DES PARENTSPlusieurs group
- Page 87 and 88: l’équipe soignante. Dans ces mom
- Page 89 and 90: ANNEXE 1Définitions de concepts cl
- Page 91 and 92: 17. Chervenak, F. A., McCullough, L
- Page 93 and 94: REMERCIEMENTS DE LA PART DE L'AUTEU
- Page 95 and 96: INTRODUCTIONÀ mesure que les progr
- Page 97 and 98: dans l’affaire Tremblay c. Daigle
- Page 99 and 100: La viabilité est conditionnelle à
- Page 101 and 102: consentement aux soins du prématur
- Page 103 and 104: libre et éclairé 52 ;Nul ne peut
- Page 105 and 106:
sont uniques selon son âge et sa c
- Page 107 and 108:
18 Tremblay c. Daigle, [1989] 2 R.C
- Page 109 and 110:
45 Robert P.KOURI, Suzanne PHILIPS-
- Page 111 and 112:
L’influence de la prématurité e
- Page 113 and 114:
critères de nature clinique et ép
- Page 115 and 116:
qualité de vie acceptable. Ainsi,
- Page 117 and 118:
RÉFÉRENCESOuvrages générauxVers